These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20428005)

  • 1. Use of brain natriuretic Peptide and bioimpedance to guide therapy in heart failure patients.
    Valle R; Aspromonte N
    Contrib Nephrol; 2010; 164():209-216. PubMed ID: 20428005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
    Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wet BNP, fluid and hemodynamic status at discharge in acute heart failure.
    Parrinello G; Torres D; Paterna S; Di Pasquale P; Licata G
    Int J Cardiol; 2010 Nov; 145(2):335-336. PubMed ID: 20045208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient monitoring and prognostic importance of B-type natriuretic peptide.
    Aspromonte N; Valle R; Peacock WF; Vanderheyden M; Maisel A
    Congest Heart Fail; 2008; 14(4 Suppl 1):30-4. PubMed ID: 18833664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
    Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
    Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
    Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.
    Santarelli S; Russo V; Lalle I; De Berardinis B; Navarin S; Magrini L; Piccoli A; Codognotto M; Castello LM; Avanzi GC; Villacorta H; Precht BLC; de Araújo Porto PB; Villacorta AS; Di Somma S;
    Intern Emerg Med; 2017 Jun; 12(4):445-451. PubMed ID: 27987064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the "5B" approach.
    Ronco C; Kaushik M; Valle R; Aspromonte N; Peacock WF
    Semin Nephrol; 2012 Jan; 32(1):129-41. PubMed ID: 22365171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in bioelectrical impedance vector analysis and phase angle in acute decompensated heart failure.
    Alves FD; Souza GC; Aliti GB; Rabelo-Silva ER; Clausell N; Biolo A
    Nutrition; 2015 Jan; 31(1):84-9. PubMed ID: 25466653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide testing for predicting adverse events following heart failure hospitalization.
    Januzzi JL; Maisel AS; Silver M; Xue Y; DeFilippi C
    Congest Heart Fail; 2012; 18 Suppl 1():S9-S13. PubMed ID: 22891803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single BNP measurement in acute heart failure does not reflect the degree of congestion.
    Omar HR; Guglin M
    J Crit Care; 2016 Jun; 33():262-5. PubMed ID: 27040515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide levels and diagnostic accuracy: excess fluid volume.
    Trojahn MM; Barilli SLS; Bernardes DDS; Pedraza LL; Aliti GB; Rabelo-Silva ER
    Rev Gaucha Enferm; 2020; 41(spe):e20190095. PubMed ID: 32294683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure.
    Massari F; Iacoviello M; Scicchitano P; Mastropasqua F; Guida P; Riccioni G; Speziale G; Caldarola P; Ciccone MM; Di Somma S
    Heart Lung; 2016; 45(4):319-26. PubMed ID: 27117421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serial assessment of natriuretic peptides in the emergency department for patients with acute decompensated heart failure.
    Disomma S; Magrini L; Pittoni V; Marino R; Peacock WF; Maisel A
    Congest Heart Fail; 2008; 14(4 Suppl 1):21-4. PubMed ID: 18772629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding "hemodynamic and fluid leads" to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation.
    Skrabal F; Pichler GP; Gratze G; Holler A
    Med Eng Phys; 2014 Jul; 36(7):896-904; discussion 896. PubMed ID: 24793409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
    Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
    J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.